Aug 29 (Reuters) - Arctic Bioscience AS ABSA.OL :
* OUTLOOK: BASED ON RECEIVED ORDER INTAKE FOR SECOND HALF OF
2023
AND GENERAL ORDER OUTLOOK WITH NEW SALES PROSPECTS ARCTIC
BIOSCIENCE AIMS FOR A TOTAL YEAR OVER YEAR REVENUE GROWTH IN
2023 OF 30-35 %
* OUTLOOK: INCLUDING EFFECTS ALSO FROM ARCTIC ALGAE,
EXPECTED FULL
YEAR EBITDA WILL BE IN RANGE OF NEGATIVE NOK 37-42 MILLION
Source text for Eikon: ID:nWkr6622Fv
Further company coverage: ABSA.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))